MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.schres.2021.07.011

Медицинская библиотека · Schizophrenia research · 2021

Association between valproate treatment for acute phase schizophrenia and risk of new onset hypothyroidism.

Zhao Ying, Wen Shi Wu, Qin Ying, Liu Yufei, Gao Yiqiao, Retnakaran Ravi, Zhang Ruiling, Zhai Desheng

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

AIM: To assess the association between acute phase treatment by valproate as an adjunctive drug and risk of new onset hypothyroidism in a large cohort of patients affected by schizophrenia.

METHODS

We conducted a retrospective cohort study in a psychiatric hospital in China between January 2016 and December 2018. We obtained approval from the Ethics Committee of the study hospital prior to the commencement of the study. Patients who were diagnosed with schizophrenia and admitted to the study hospital during the study period with thyroid function tests at admission and during hospitalization were included. Patients with abnormal thyroid function at admission were excluded. Hypothyroidism, defined as TSH>4.2 mU/L or on L-thyroxine treatment, was the primary outcome. The primary exposure was adjunctive valproate plus atypical antipsychotics (AAPD), the secondary exposure was lithium plus AAPD and the comparison group was AAPD only. Adjusted relative risk (RR) and 95% confidence interval (CI) were estimated by log-binomial model to assess the independent association between valproate treatment and risk of hypothyroidism.

RESULTS

A total of 1622 eligible patients were included the final analysis. Rate of new onset hypothyroidism was 10.7% and 20.9% in AAPD only and valproate plus AAPD groups, respectively. Adjusted RR (95% CI) for valproate plus AAPD was 1.85 (1.44-2.38), with AAPD only group as reference. Similarly, adjusted RR (95% CI) for lithium plus AAPD was 1.93 (1.32-2.69).

CONCLUSION

Similar with lithium, valproate as adjunctive drug is associated with increased risk of new onset hypothyroidism during acute phase treatment for schizophrenia.

Для цитирования: Zhao Ying, Wen Shi Wu, Qin Ying, Liu Yufei, Gao Yiqiao, Retnakaran Ravi, Zhang Ruiling, Zhai Desheng. Association between valproate treatment for acute phase schizophrenia and risk of new onset hypothyroidism.. Schizophrenia research. 2021. DOI: 10.1016/j.schres.2021.07.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.